Overall rank by patents
#5,734
of 49,997 tracked assignees
USPTO PatentsView assignee record - 59 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Aerin ranks #5,734 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R5734 · US Corporation #5,734 · 59 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Accuvein, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Aerin Medical · this assignee
36 score
Dyax · near
36 score
Magnolia White · near
36 score
Mako Rentals · near
36 score
WaveLight · near
36 score
3D Lighting… · lowest
7 score
What this shows Aerin's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Aerin Medical Inc. is a focused PatentsView assignee: 7 CPC subclasses with 89.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (8 grants) versus a trough of 2 in 2024. By volume, Aerin sits between Arcturus Therapeutics, Inc. and Banjo Corporation.
From 2019–2021 to 2022–2024, Aerin Medical Inc. moved from 20 to 13 grants (0.65x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Arcturus Therapeutics, Inc.
59 patents
Arris Technology, Inc.
59 patents
Auras Technology Co., Ltd.
59 patents
Accuvein, Inc.
59 patents
Bauerfeind AG
59 patents
Baylor Research Institute
59 patents
BP Exploration Operating Company Limited
59 patents
Banjo Corporation
59 patents
Aerin Medical Inc.
59 patents
What this shows Aerin holds 59 patents at rank #5,738, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,738 in granted patent volume.
Other assignees with the most granted patents in Aerin's primary technology class.
Two PlainPatent-derived peer sets for Aerin, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (36 here).
Nearest assignees by average claims per patent (13.8 here).
Aerin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 8.5% |
| 2016 | 6 | 10.2% |
| 2017 | 3 | 5.1% |
| 2018 | 4 | 6.8% |
| 2019 | 8 | 13.6% |
| 2020 | 8 | 13.6% |
| 2021 | 4 | 6.8% |
| 2022 | 6 | 10.2% |
| 2023 | 5 | 8.5% |
| 2024 | 2 | 3.4% |
| 2025partial year | 8 | 13.6% |
Top 7 of 7 technology areas
Overall rank by patents
#5,734
of 49,997 tracked assignees
36.1 out of 100
What to do with this data
Aerin Medical Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.